Home / Dabigatran Etexilate / Germany
DE ATC B01AE07 · updated 2 Nov 2026
Dabigatran Etexilate shortage in Germany
Is there a Dabigatran Etexilate shortage in Germany?
Yes. As of 2 Nov 2026, 6 Dabigatran Etexilate products are reported short in Germany, the first since 21 Apr 2026. The company estimate for the return is 16 Nov 2026 (latest 15 Dec 2026). Main reason: active ingredient shortage.
Also short in Canada, Italy, Spain, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Dabigatranetexilat Viatris 150 mg Hartkapseln | Viatris Germany GmbH | 21 Apr 2026 | 16 Nov 2026 | Increased demand Erhöhte Nachfrage |
| DE | Dabigatranetexilat Viatris 150 mg Hartkapseln | Viatris Germany GmbH | 21 Apr 2026 | 16 Nov 2026 | Increased demand Erhöhte Nachfrage |
| DE | Dabigatranetexilat Viatris 110 mg Hartkapseln | Viatris Germany GmbH | 6 Aug 2026 | 16 Nov 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Dabigatranetexilat Viatris 110 mg Hartkapseln | Viatris Germany GmbH | 6 Aug 2026 | 16 Nov 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Dabigatranetexilat Viatris 110 mg Hartkapseln | Viatris Germany GmbH | 6 Aug 2026 | 16 Nov 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Dabigatranetexilat Viatris 75 mg Hartkapseln | Viatris Germany GmbH | 6 Aug 2026 | 15 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.